Herg

Results: 73



#Item
41Health / Proteins / Cardiac dysrhythmia / Syndromes / KvLQT1 / Pharmaceutical sciences / Long QT syndrome / HERG / In vitro / Ion channels / Pharmacology / Biology

Microsoft Word - CCCA5AC4.doc

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-01-05 16:25:57
42Medicine / Cardiac dysrhythmia / HERG / Long QT syndrome / QT interval / Torsades de pointes / KvLQT1 / Ventricular tachycardia / Cardiac action potential / Biology / Cardiac electrophysiology / Physiology

ICH S7B Guideline Step 2 Revision The Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-09-10 06:20:27
43Cardiac electrophysiology / Circulatory system / Piperazines / QT interval / Channelopathy / Syndromes / Long QT syndrome / HERG / Torsades de pointes / Cardiac dysrhythmia / Chemistry / Physiology

Guidance for Industry E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-10-17 17:52:11
44Pharmacology / Cardiac dysrhythmia / Syndromes / QT interval / Long QT syndrome / Title 21 of the Code of Federal Regulations / Qt / Ex vivo / Software / HERG / Medicinal chemistry

Microsoft Word - 04D-0378-EC3-Attach-2.doc

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-01-05 16:25:58
45Physiology / Medicine / Pharmacology / QT interval / Channelopathy / Syndromes / HERG / Long QT syndrome / Torsades de pointes / Health / Cardiac dysrhythmia / Cardiac electrophysiology

inical Evaluation of QT Prolongati 0 Docket 04D-0377, ICH El Docket 04D-0378, ICH S7B, Nonclinical Evaluation of QT Prolongation Page 14

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-01-05 16:25:54
46Syndromes / Biology / Ion channels / Rare diseases / Long QT syndrome / KvLQT1 / KCNE1 / Romano-Ward syndrome / HERG / Health / Channelopathy / Cardiac dysrhythmia

Genes in Long QT Syndromes Andrew D. Krahn MD FRCPC Coworkers: Michael Gollob MD* George J. Klein MD

Add to Reading List

Source URL: www.sads.ca

Language: English - Date: 2013-03-10 20:04:19
47Physiology / Cardiac electrophysiology / Ion channels / Channelopathy / Syndromes / HERG / QT interval / Long QT syndrome / Torsades de pointes / Biology / Cardiac dysrhythmia / Medicine

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL

Add to Reading List

Source URL: www.ich.org

Language: English - Date: 2012-06-22 05:08:05
48Cardiac electrophysiology / Circulatory system / Piperazines / QT interval / Channelopathy / Syndromes / Long QT syndrome / HERG / Torsades de pointes / Cardiac dysrhythmia / Chemistry / Physiology

Guidance for Industry E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2006-11-13 08:05:27
49Medicine / Long QT syndrome / HERG / KCNE1 / Ventricular fibrillation / Sudden cardiac death / Torsades de pointes / KvLQT1 / QT interval / Cardiac dysrhythmia / Health / Biology

Heart Rhythm[removed], 60 – 64 www.heartrhythmjournal.com Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome

Add to Reading List

Source URL: www.sads.org

Language: English - Date: 2010-07-30 19:42:54
50Amines / Antitussives / Dextropropoxyphene / Eli Lilly and Company / Propionates / Alprazolam / Lidocaine / Antiarrhythmic agent / HERG / Chemistry / Medicine / Pharmacology

DCRP consult to evaluate nonclinical cardiac safety data for propoxyphene (January 21, 2010 memo)

Add to Reading List

Source URL: www.fda.gov

Language: English
UPDATE